<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02521740</url>
  </required_header>
  <id_info>
    <org_study_id>1318184</org_study_id>
    <nct_id>NCT02521740</nct_id>
  </id_info>
  <brief_title>CAREGIVER2, Caregiver's Health Assessment : Clinical and Biological Markers</brief_title>
  <official_title>Soutien Des Soins Informels Aux Personnes âgées Fragiles : Accompagnement Des Aidants Sur Base d'Une évaluation Clinique et Biologique de la Charge de Soins.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire Dinant Godinne - UCL Namur</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Liege GIGA-I3</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Namur RUCB</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre Hospitalier Universitaire Dinant Godinne - UCL Namur</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Providing care for a disabled elderly may represent a risk for the health of the caregiver.
      The objective of the study is to assess the impact of caregiving in terms of clinical and
      biological markers in relation to disability and cognitive impairment.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators hypothesize that an accumulation of stressful events related to care giving
      may induce a stress response to the caregiver. This stress response can be measured by
      biological markers (inflammation, transcription and immunity) and also by clinical markers
      (frailty, physical performance, nutrition). This stress response can be influenced by the
      subjective burden of the caregiver and by the severity of the disease of the care receiver
      (Activity of daily life capabilities, cognitive function, behavioral disturbance).
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>March 2015</start_date>
  <completion_date type="Anticipated">October 2017</completion_date>
  <primary_completion_date type="Anticipated">October 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Levels of biomarkers across groups</measure>
    <time_frame>at baseline</time_frame>
    <description>biomarkers of inflammation (cortisol, high sensitive C-Reactive Protein,Interleukin-6), immunity (TRECS, telomere length) and transcriptomics/epigenetics</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Relation between biomarkers, subjective burden and the care receiver situation</measure>
    <time_frame>at baseline</time_frame>
    <description>biomarkers of inflammation (cortisol, high sensitive C-Reactive Protein,Interleukin-6), immunity (TRECS, telomere length) and transcriptomics/epigenetics and their relations with the Zarit burden, the caregiver reaction assessment, the depression scale and the sense of coherence scale and with the situation of the care receiver ( Katz index, cognitive impairment, behavioral disturbance)</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Relation between biomarkers, subjective burden and the care receiver situation</measure>
    <time_frame>at baseline</time_frame>
    <description>biomarkers of inflammation (cortisol, high sensitive C-Reactive Protein,Interleukin-6), immunity (TRECS, telomere length) and transcriptomics/epigenetics and their relations with the Zarit burden, the caregiver reaction assessment, the depression scale and the sense of coherence scale and with the situation of the care receiver ( Katz index, cognitive impairment, behavioral disturbance)</description>
  </other_outcome>
  <other_outcome>
    <measure>comparison of health events</measure>
    <time_frame>after 12 month</time_frame>
    <description>Institutionalization, increase of formal home help services, hospitalisations</description>
  </other_outcome>
  <other_outcome>
    <measure>relation between biomarkers at baseline and functional decline</measure>
    <time_frame>after 12 month</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Levels of clinical markers across groups</measure>
    <time_frame>at baseline and after 12 month</time_frame>
    <description>frailty, physical performance, nutrition, depression</description>
  </other_outcome>
  <other_outcome>
    <measure>relation between biomarkers at baseline and burden</measure>
    <time_frame>after 12 month</time_frame>
  </other_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Caregivers</condition>
  <arm_group>
    <arm_group_label>caregivers</arm_group_label>
    <description>someone who takes care and lives with a disabled elderly</description>
  </arm_group>
  <arm_group>
    <arm_group_label>controls</arm_group_label>
    <description>someone who lives with an healthy elderly</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Research questionnaires, blood sample</intervention_name>
    <description>assessment of health (frailty, nutrition, physical performance, depression, burden, sense of coherence, caregiver reaction)</description>
    <arm_group_label>caregivers</arm_group_label>
    <arm_group_label>controls</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood samples taken between 8 and 11 am. Blood parameters including cell counts and assays of
      acute phase proteins (C-reactive protein (CRP), albumin, pre-albumin) are determined
      according to the routine of the hospital.

      PBMC are isolated by centrifugation in a Lympho-Ficoll gradient by the biobank of CHU Dinant
      Godinne.

      Collected plasma is stored at −80 °C until analysis. The amounts of insulin-like growth
      factor-1 (IGF-1), interleukin-6 (IL-6) are essayed by enzyme-linked immunosorbent assay
      (ELISA).

      PBMC are sent to Liege (GIGAI3) and Namur (URBC) for respectively ADN and ARN analyses.

      ADN analyses concerned the immunity markers and ARN analyses concerned the transcriptomics
      and epigenetic markers.

      The biobank of the CHU Dinant-Godinne meets the requirements of the quality book developed by
      the biobanks of Walonnie-Bruxelles (BWB).
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        -  caregivers of a community dwelling dependent elderly (≥70years)

          -  controls : poeple who lives with a healthy elderly (≥70years)
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  living with the care-receiver ( or with a healthy elderly for the controls)

          -  care-receiver dependent for at least one Activity of the daily living ( Katz index) or
             having cognitive disorder ( &gt;2 Global Deterioration Scale)

        Exclusion Criteria:

          -  institutionalised elderly

          -  inability to understand and speak french

          -  Acute disease within the past month

          -  Anti-inflammatory or immuno-suppressive treatment

          -  End-of-life care
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>70 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marie de Saint-Hubert, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>CHUDinant-Godinne</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>florence potier, MD</last_name>
    <phone>0032/81 42 21 75</phone>
    <email>florence.potier@uclouvain.be</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Marie de Saint-Hubert, MD, PhD</last_name>
    <email>marie.desainthubert@uclouvain.be</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHU Dinant-Godinne</name>
      <address>
        <city>Mont-Godinne</city>
        <state>Yvoir</state>
        <zip>5530</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>florence potier, MD</last_name>
      <email>florence.potier@uclouvain.be</email>
    </contact>
    <investigator>
      <last_name>Florence Potier, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>August 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 29, 2015</study_first_submitted>
  <study_first_submitted_qc>August 10, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 13, 2015</study_first_posted>
  <last_update_submitted>August 10, 2015</last_update_submitted>
  <last_update_submitted_qc>August 10, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 13, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Centre Hospitalier Universitaire Dinant Godinne - UCL Namur</investigator_affiliation>
    <investigator_full_name>Professor Maximilien Gourdin</investigator_full_name>
    <investigator_title>Directeur Médical adjoint aux missions universitaires</investigator_title>
  </responsible_party>
  <keyword>biological marker</keyword>
  <keyword>frailty</keyword>
  <keyword>burden</keyword>
  <keyword>nutrition</keyword>
  <keyword>elderly</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

